Open label TBS-DLPFC

DEVICE2 trials

Sponsors

Stanford University

Conditions

Treatment Resistant Depression

Unknown Phase

Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression (SAINT-TRD)

CompletedNCT03068715

Stanford UniversityTreatment Resistant Depression

Start: 2017-03-20End: 2021-01-09Updated: 2022-05-18

SAINT for Treatment of Preoperative Depression to Reduce Opioid Use Following Arthroplasty

WithdrawnNCT04195308

Stanford UniversityTreatment Resistant Depression

Start: 2024-06-30End: 2026-11-30Updated: 2022-12-14

Related Papers

Neurophysiological signatures of Stanford Neuromodulation Therapy in treatment resistant depression.

2026-09-02

Network effects of Stanford Neuromodulation Therapy (SNT) in treatment-resistant major depressive disorder: a randomized, controlled trial

Translational Psychiatry2023-07-0325 citations